Literature DB >> 10886561

G1 kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth.

H C Huang1, P A Preisig.   

Abstract

BACKGROUND: Diabetes mellitus-induced nephromegaly is thought to involve both hyperplastic and hypertrophic proximal tubule cell growth. The temporal relationship between these growth patterns and the mechanisms that mediate them are unknown.
METHODS: Renal growth was assayed in isolated renal proximal tubules harvested from diabetic rats. Diabetes mellitus was induced by streptozotocin.
RESULTS: Following the induction of a diabetic state, there was a progressive increase in the kidney:body weight ratio. This was associated with an increase in 5-bromo-2-deoxyuridine incorporation (marker for hyperplastic cell growth) at day 2, which returned to baselines levels by day 4, and an increase in the protein:DNA ratio (marker for hypertrophic cell growth), which was clearly evident by day 10. Thus, diabetes-induced proximal tubule growth involved an initial hyperplastic, followed by a hypertrophic, growth period. During the hyperplastic growth period, both cdk4/cyclin D (cyclin D) and cdk2/cyclin E (cyclin E) kinase activities were increased. The switch between the growth periods was associated with continued activation of cyclin D, but inhibition of cyclin E kinase. The reduction in cyclin E kinase activity correlated with a reduction in cdk2/cyclin E complex abundance and an increased abundance of cyclin kinase inhibitors in cdk2/cyclin E complexes that did form. Also associated with the switch in growth patterns was a change in transforming growth factor-beta (TGF-beta) receptor expression. During the hyperplastic growth period, TGF-beta receptor II expression was decreased, while during the hypertrophic growth period, there was both a return of receptor II expression to baseline levels and increased expression of receptor I. Consistent with an increase in TGF-beta signaling during hypertrophy, there was an increase in Smad 2/3 protein expression and an increase in the abundance of Smad 2/4 complexes.
CONCLUSIONS: Diabetes-induced proximal tubule growth involves an initial hyperplastic growth period that switches to a hypertrophic growth period within a couple of days. The pattern of G1 kinase activity associated with the growth pattern switch demonstrates that the hypertrophy is mediated by a cell cycle-dependent mechanism. Regulation of TGF-beta receptor expression and signaling activity through the Smad protein cascade possibly plays a role in the growth pattern switch.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886561     DOI: 10.1046/j.1523-1755.2000.00151.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

1.  Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes.

Authors:  Joseph Satriano; Hadi Mansoury; Aihua Deng; Kumar Sharma; Volker Vallon; Roland C Blantz; Scott C Thomson
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-26       Impact factor: 4.249

Review 2.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

3.  Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.

Authors:  Kelli M Sas; Hong Yin; Wayne R Fitzgibbon; Catalin F Baicu; Michael R Zile; Stacy L Steele; May Amria; Takamitsu Saigusa; Jason Funk; Marlene A Bunni; Gene P Siegal; Brian J Siroky; John J Bissler; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-22

4.  PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy.

Authors:  Nirmalya Dey; Nandini Ghosh-Choudhury; Falguni Das; Xiaonan Li; Balachandar Venkatesan; Jeffrey L Barnes; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

5.  High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases.

Authors:  G Wolf; R Schroeder; G Zahner; R A Stahl; S J Shankland
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes.

Authors:  Nirmalya Dey; Falguni Das; Meenalakshmi M Mariappan; Chandi Charan Mandal; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

7.  Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients.

Authors:  David P Choma; Roberto Vanacore; Helen Naylor; Ian A Zimmerman; Andrei Pavlichenko; Artyom Pavlichenko; Liberty Foye; David P Carbone; Raymond C Harris; Mikhail M Dikov; Elena E Tchekneva
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-30

Review 8.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

Review 9.  A transgenic mouse model for studying the role of the parathyroid hormone-related protein system in renal injury.

Authors:  Ricardo J Bosch; Arantxa Ortega; Adriana Izquierdo; Ignacio Arribas; Jordi Bover; Pedro Esbrit
Journal:  J Biomed Biotechnol       Date:  2010-10-31

10.  Erk 1,2 phosphorylates p27(Kip1): Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells.

Authors:  G Wolf; R Reinking; G Zahner; R A K Stahl; S J Shankland
Journal:  Diabetologia       Date:  2003-07-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.